At a glance
- Originator AstraZeneca
- Class Antihypertensives; Small molecules
- Mechanism of Action Calcium channel antagonists; Potassium-sparing diuretics
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Hypertension
Most Recent Events
- 06 Sep 2000 Discontinued-Preclinical for Heart failure in USA (IV)
- 06 Sep 2000 Discontinued-Preclinical for Heart failure in USA (PO)
- 06 Sep 2000 Discontinued-Preclinical for Hypertension in USA (IV)